Effect of High- vs Low-Dose Tranexamic Acid Infusion on Need for Red Blood Cell Transfusion and Adverse Events in Patients Undergoing Cardiac Surgery

医学 氨甲环酸 麻醉 不利影响 养生 临床终点 心脏外科 丸(消化) 深静脉 体外循环 肺栓塞 心肌梗塞 输血 外科 血栓形成 随机对照试验 心脏病学 内科学 失血
作者
Jia Shi,Chenghui Zhou,Wei Pan,Hansong Sun,Sheng Liu,Wei Feng,Weijian Wang,Zhaoyun Cheng,Yang Wang,Zhe Zheng,Liqing Wang,Yunhu Song,Chuntao Yu,Xin Wang,Xianqiang Wang,Hongguang Fan,Yang Yan,Fei Xu,Ge Gao,Yan Zhang
出处
期刊:JAMA [American Medical Association]
卷期号:328 (4): 336-336 被引量:66
标识
DOI:10.1001/jama.2022.10725
摘要

Tranexamic acid is recommended for reducing blood loss and transfusion in cardiac surgery. However, it remains unknown whether a high dose of tranexamic acid provides better blood-sparing effect than a low dose without increasing the risk of thrombotic complications or seizures in cardiac surgery.To compare the efficacy and adverse events of high-dose vs low-dose tranexamic acid in patients undergoing cardiac surgery with cardiopulmonary bypass.Multicenter, double-blind, randomized clinical trial among adult patients undergoing cardiac surgery with cardiopulmonary bypass. The study enrolled 3079 patients at 4 hospitals in China from December 26, 2018, to April 21, 2021; final follow-up was on May 21, 2021.Participants received either a high-dose tranexamic acid regimen comprising a 30-mg/kg bolus, a 16-mg/kg/h maintenance dose, and a 2-mg/kg prime (n = 1525) or a low-dose regimen comprising a 10-mg/kg bolus, a 2-mg/kg/h maintenance dose, and a 1-mg/kg prime (n = 1506).The primary efficacy end point was the rate of allogeneic red blood cell transfusion after start of operation (superiority hypothesis), and the primary safety end point was a composite of the 30-day postoperative rate of mortality, seizure, kidney dysfunction (stage 2 or 3 Kidney Disease: Improving Global Outcomes [KDIGO] criteria), and thrombotic events (myocardial infarction, ischemic stroke, deep vein thrombosis, and pulmonary embolism) (noninferiority hypothesis with a margin of 5%). There were 15 secondary end points, including the individual components of the primary safety end point.Among 3079 patients who were randomized to treatment groups (mean age, 52.8 years; 38.1% women), 3031 (98.4%) completed the trial. Allogeneic red blood cell transfusion occurred in 333 of 1525 patients (21.8%) in the high-dose group and 391 of 1506 patients (26.0%) in the low-dose group (risk difference [RD], -4.1% [1-sided 97.55% CI, -∞ to -1.1%]; relative risk, 0.84 [1-sided 97.55% CI, -∞ to 0.96; P = .004]). The composite of postoperative seizure, thrombotic events, kidney dysfunction, and death occurred in 265 patients in the high-dose group (17.6%) and 249 patients in the low-dose group (16.8%) (RD, 0.8%; 1-sided 97.55% CI, -∞ to 3.9%; P = .003 for noninferiority). Fourteen of the 15 prespecified secondary end points were not significantly different between groups, including seizure, which occurred in 15 patients (1.0%) in the high-dose group and 6 patients (0.4%) in the low-dose group (RD, 0.6%; 95% CI, -0.0% to 1.2%; P = .05).Among patients who underwent cardiac surgery with cardiopulmonary bypass, high-dose compared with low-dose tranexamic acid infusion resulted in a modest statistically significant reduction in the proportion of patients who received allogeneic red blood cell transfusion and met criteria for noninferiority with respect to a composite primary safety end point consisting of 30-day mortality, seizure, kidney dysfunction, and thrombotic events.ClinicalTrials.gov Identifier: NCT03782350.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
琳琅发布了新的文献求助10
刚刚
xue完成签到 ,获得积分10
1秒前
liars完成签到 ,获得积分10
1秒前
搞怪人雄完成签到,获得积分10
4秒前
落后的夜阑完成签到,获得积分10
4秒前
大橙子发布了新的文献求助10
7秒前
彪行天下完成签到,获得积分10
12秒前
danli完成签到 ,获得积分10
13秒前
guangyu完成签到,获得积分10
15秒前
学术老6完成签到,获得积分10
16秒前
c123完成签到 ,获得积分10
18秒前
恐怖稽器人完成签到,获得积分10
18秒前
WXR完成签到,获得积分10
19秒前
科研小白完成签到,获得积分10
19秒前
20秒前
可爱丸子完成签到,获得积分10
20秒前
皮汤汤完成签到 ,获得积分10
21秒前
JXDYYZK完成签到,获得积分10
22秒前
SYLH应助lu采纳,获得10
22秒前
Servant2023完成签到,获得积分10
22秒前
鸽子的迷信完成签到,获得积分10
24秒前
nine2652完成签到 ,获得积分10
25秒前
烂漫的睫毛完成签到 ,获得积分10
27秒前
量子星尘发布了新的文献求助10
27秒前
陈老太完成签到 ,获得积分10
28秒前
宇宇宇c完成签到,获得积分10
29秒前
zxt完成签到,获得积分10
30秒前
大橙子发布了新的文献求助10
33秒前
聪明静柏完成签到 ,获得积分10
35秒前
kimiwanano完成签到,获得积分10
37秒前
lu完成签到,获得积分10
38秒前
Profeto应助齐嫒琳采纳,获得10
39秒前
40秒前
情怀应助科研通管家采纳,获得10
41秒前
从来都不会放弃zr完成签到,获得积分10
45秒前
1459完成签到,获得积分10
47秒前
行者+完成签到,获得积分10
47秒前
GongSyi完成签到 ,获得积分10
48秒前
Boris完成签到 ,获得积分10
50秒前
哭泣笑柳完成签到,获得积分10
50秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038157
求助须知:如何正确求助?哪些是违规求助? 3575869
关于积分的说明 11373842
捐赠科研通 3305650
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022